Tejnaksh Healthcare Limited Announces Q3FY26 Financial Results
Tejnaksh Healthcare Limited announced Q3FY26 results with consolidated revenue of ₹261.62 lakhs and net profit of ₹28.82 lakhs, showing decline from previous year's ₹318.98 lakhs revenue and ₹55.54 lakhs profit. Nine-month consolidated performance showed revenue of ₹823.40 lakhs and profit of ₹83.24 lakhs. Standalone Q3FY26 results reported revenue of ₹169.08 lakhs and profit of ₹22.78 lakhs. The Board approved results on February 07, 2026, following audit committee review.

*this image is generated using AI for illustrative purposes only.
Tejnaksh Healthcare Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's Board of Directors approved both consolidated and standalone results at their meeting held on February 07, 2026, following review and recommendation by the Audit Committee.
Consolidated Financial Performance
The company's consolidated operations showed mixed performance during the quarter. Revenue from operations declined to ₹261.62 lakhs in Q3FY26 compared to ₹318.98 lakhs in the corresponding quarter of the previous year, representing a decrease from the prior year period.
| Metric | Q3FY26 | Q3FY25 | Nine Months FY26 | Nine Months FY25 |
|---|---|---|---|---|
| Revenue from Operations | ₹261.62 lakhs | ₹318.98 lakhs | ₹823.40 lakhs | ₹968.22 lakhs |
| Total Income | ₹268.64 lakhs | ₹336.40 lakhs | ₹849.07 lakhs | ₹1,001.44 lakhs |
| Net Profit | ₹28.82 lakhs | ₹55.54 lakhs | ₹83.24 lakhs | ₹180.72 lakhs |
| Basic EPS | ₹0.14 | ₹0.38 | ₹0.41 | ₹0.90 |
For the nine-month period, consolidated revenue from operations was ₹823.40 lakhs compared to ₹968.22 lakhs in the previous year. Net profit for the nine months stood at ₹83.24 lakhs against ₹180.72 lakhs in the corresponding period last year.
Standalone Financial Results
On a standalone basis, the company reported revenue from operations of ₹169.08 lakhs for Q3FY26, down from ₹223.82 lakhs in Q3FY25. Net profit on standalone basis was ₹22.78 lakhs compared to ₹71.94 lakhs in the previous year quarter.
| Parameter | Q3FY26 Standalone | Q3FY25 Standalone | Nine Months FY26 | Nine Months FY25 |
|---|---|---|---|---|
| Revenue from Operations | ₹169.08 lakhs | ₹223.82 lakhs | ₹540.66 lakhs | ₹639.35 lakhs |
| Total Income | ₹175.05 lakhs | ₹237.74 lakhs | ₹563.28 lakhs | ₹668.38 lakhs |
| Net Profit | ₹22.78 lakhs | ₹71.94 lakhs | ₹87.56 lakhs | ₹186.61 lakhs |
| Basic EPS | ₹0.11 | ₹0.36 | ₹0.43 | ₹0.92 |
For the nine-month standalone period, revenue from operations was ₹540.66 lakhs versus ₹639.35 lakhs in the previous year, while net profit stood at ₹87.56 lakhs compared to ₹186.61 lakhs.
Operational Highlights
The company operates primarily in the medical and healthcare services segment. Key expense categories during Q3FY26 included employee benefits expense of ₹33.41 lakhs on consolidated basis and ₹17.98 lakhs on standalone basis. Other expenses constituted a significant portion at ₹134.49 lakhs for consolidated operations.
Depreciation and amortization expense was ₹36.39 lakhs for the quarter on consolidated basis, while finance costs stood at ₹3.89 lakhs. The company maintained its paid-up equity share capital at ₹1,015.68 lakhs with a face value of ₹5 per share.
Regulatory Compliance
The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The statutory auditors, Maheshwari & Co., conducted a limited review of both consolidated and standalone results without any modifications to their review reports.
The company noted that the Government of India's consolidation of 29 existing labour legislations into four unified labour codes on November 21, 2025, had no material impact on employee benefit expenses for the reporting period.
Historical Stock Returns for Tejnaksh Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.89% | +15.28% | +5.13% | -16.89% | -33.43% | -70.93% |

























